Timi score Calculator for Uanstemi
Calculate timiscore uanstemi quickly with our cardiovascular system tool. Get results based on evidence-based formulas with clear explanations.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Timi score Calculator for Uanstemi
Calculator
Adjust values & calculateEnter your values below. Every result is computed in your browser — no data is sent to any server.
Formula: TIMI Score = Sum of 7 binary risk factors (0-7 points)
Worked example — TIMI Score: 0/7 | Low Risk | 14-day event rate: 4.7% | Conservative management appropriate
Formula
TIMI Score = Sum of 7 binary risk factors (0-7 points)
Each of seven factors adds one point: age >= 65, >= 3 CAD risk factors, known CAD with >= 50% stenosis, aspirin use in past 7 days, >= 2 anginal episodes in 24 hours, ST deviation >= 0.5mm, and elevated cardiac markers. Higher scores indicate greater 14-day event risk.
Worked Examples
Example 1: Low-Risk UA/NSTEMI Assessment
Problem:A 52-year-old patient presents with chest pain, has 1 CAD risk factor (smoking), no known CAD, not on aspirin, single episode of angina, no ST changes, and normal troponin.
Solution:TIMI Score calculation: Age >= 65: No (0 points) CAD risk factors >= 3: No, only 1 (0 points) Known CAD >= 50% stenosis: No (0 points) Aspirin use past 7 days: No (0 points) Severe angina >= 2 episodes/24h: No (0 points) ST deviation >= 0.5mm: No (0 points) Elevated cardiac markers: No (0 points) Total TIMI Score = 0
Result:TIMI Score: 0/7 | Low Risk | 14-day event rate: 4.7% | Conservative management appropriate
Example 2: High-Risk UA/NSTEMI Assessment
Problem:A 70-year-old patient on aspirin with hypertension, diabetes, smoking, and hypercholesterolemia (4 risk factors). Known prior coronary stenting. Had 3 angina episodes in past 24 hours with 1mm ST depression and elevated troponin.
Solution:TIMI Score calculation: Age >= 65: Yes (+1 point) CAD risk factors >= 3: Yes, 4 factors (+1 point) Known CAD >= 50% stenosis: Yes, prior stenting (+1 point) Aspirin use past 7 days: Yes (+1 point) Severe angina >= 2 episodes/24h: Yes, 3 episodes (+1 point) ST deviation >= 0.5mm: Yes, 1mm depression (+1 point) Elevated cardiac markers: Yes, troponin elevated (+1 point) Total TIMI Score = 7
Result:TIMI Score: 7/7 | High Risk | 14-day event rate: 40.9% | Urgent invasive strategy recommended
Frequently Asked Questions
What is the TIMI Risk Score for UA/NSTEMI and what does it predict?
The TIMI (Thrombolysis In Myocardial Infarction) Risk Score for UA/NSTEMI is a validated clinical tool that predicts the risk of death, myocardial infarction, or urgent revascularization within 14 days of presentation in patients with unstable angina or non-ST elevation myocardial infarction. Developed by Antman and colleagues in 2000, the score uses seven easily assessed clinical variables, each worth one point, creating a simple 0 to 7 scale. The score was derived from the TIMI 11B trial and validated in multiple subsequent studies and registries. Its primary clinical utility is in guiding the decision between conservative medical management and an early invasive strategy with cardiac catheterization. Higher scores indicate greater benefit from early invasive management with dual antiplatelet therapy and anticoagulation.
What are the seven variables in the TIMI Risk Score for UA/NSTEMI?
The seven variables in the TIMI Risk Score for UA/NSTEMI are each scored as present (1 point) or absent (0 points). First, age 65 years or older. Second, having at least three coronary artery disease risk factors, which include family history of coronary artery disease, hypertension, hypercholesterolemia, diabetes, and current smoking. Third, known coronary artery disease defined as prior coronary stenosis of 50 percent or greater documented by catheterization. Fourth, aspirin use within the past seven days, which paradoxically indicates higher risk because it suggests aspirin-refractory disease. Fifth, at least two episodes of severe anginal pain within the past 24 hours. Sixth, ST-segment deviation of 0.5 millimeters or more on the presenting electrocardiogram. Seventh, elevated serum cardiac biomarkers such as troponin or CK-MB.
How does the TIMI score guide treatment decisions in acute coronary syndromes?
The TIMI score directly influences the choice between conservative and invasive management strategies in UA/NSTEMI patients. Patients with low scores (0 to 2) have a 14-day event rate under 8.3 percent and may be managed conservatively with medical therapy and non-invasive stress testing for risk stratification. Intermediate-risk patients (scores 3 to 4) have event rates of 13 to 20 percent and generally benefit from an early invasive strategy with cardiac catheterization within 24 to 72 hours. High-risk patients (scores 5 to 7) have event rates exceeding 26 percent and should receive urgent invasive evaluation within 24 hours along with intensive antiplatelet therapy including glycoprotein IIb/IIIa inhibitors or P2Y12 inhibitors. Current ACC/AHA guidelines incorporate the TIMI score as one factor in determining the timing and aggressiveness of intervention.
Why does aspirin use in the past week increase the TIMI risk score?
The inclusion of recent aspirin use as a risk-increasing variable may seem counterintuitive since aspirin is a cornerstone of acute coronary syndrome treatment. However, patients who are already taking aspirin and still develop UA/NSTEMI have demonstrated aspirin-refractory disease, meaning their atherothrombotic process has overcome the antiplatelet effect of aspirin. This indicates more aggressive underlying pathology and a higher likelihood of adverse outcomes. These patients often have more extensive coronary artery disease, more active plaque biology, and greater thrombotic potential. The aspirin criterion also serves as a marker for patients with known cardiovascular disease who are already on preventive therapy, suggesting established vascular disease burden. Studies have confirmed that this variable independently predicts worse outcomes even after adjusting for other risk factors.
What cardiac biomarkers are considered elevated for TIMI scoring purposes?
The elevated cardiac biomarker criterion in the TIMI score originally referred to any elevation of creatine kinase-MB (CK-MB) fraction or troponin above the institutional upper limit of normal. In modern practice, high-sensitivity troponin assays (hs-cTnI or hs-cTnT) have largely replaced CK-MB as the biomarker of choice for myocardial injury detection. Any troponin elevation above the 99th percentile of a normal reference population is considered positive. High-sensitivity assays can detect much smaller amounts of myocardial necrosis, which has improved early diagnosis but also raised the challenge of distinguishing acute coronary syndromes from other causes of troponin elevation such as heart failure, pulmonary embolism, sepsis, and renal failure. Serial troponin measurements showing a rising or falling pattern are particularly useful for confirming acute myocardial injury.
How does the TIMI score for UA/NSTEMI differ from the TIMI score for STEMI?
The TIMI scores for UA/NSTEMI and STEMI are completely different scoring systems designed for different clinical scenarios. The UA/NSTEMI version uses seven dichotomous variables (present or absent) to predict 14-day events including death, MI, and need for revascularization, with scores ranging from 0 to 7. The STEMI version uses different variables including age ranges, vital signs, Killip class, body weight, anterior ST elevation, time to treatment, and diabetes/hypertension/angina history. It predicts 30-day mortality specifically, with scores ranging from 0 to 14. The two scores should never be interchanged because they apply to fundamentally different clinical presentations. UA/NSTEMI involves partial coronary occlusion with subendocardial ischemia, while STEMI involves complete coronary occlusion requiring emergent reperfusion therapy.
What are the limitations of the TIMI Risk Score in clinical practice?
The TIMI Risk Score has several recognized limitations despite its widespread use and validation. The score uses equal weighting for all seven variables, which may not reflect their true relative importance. Some clinicians argue that troponin elevation and ST changes should carry more weight than age alone. The score does not account for renal function, which is a powerful predictor of outcomes in acute coronary syndromes. It also does not incorporate newer biomarkers such as BNP or NT-proBNP that have proven prognostic value. The original validation cohorts may not fully represent current patient demographics, and treatment advances since 2000 have improved outcomes across all risk categories. Additionally, the score provides population-level risk estimates rather than individual patient predictions, and clinical judgment should always complement any scoring system.
How should ECG findings be interpreted for the TIMI score ST deviation criterion?
The ST-segment deviation criterion requires at least 0.5 millimeters (half a small box on standard ECG paper) of ST-segment depression or transient ST-segment elevation in at least two contiguous leads on the presenting ECG. ST-segment depression indicates subendocardial ischemia and is the more common finding in UA/NSTEMI. The deviation must be new or presumed new and measured at the J-point relative to the baseline (PR segment or TP segment). It is important to distinguish true ischemic ST changes from other causes of ST deviation including left ventricular hypertrophy, digitalis effect, bundle branch block, pericarditis, and early repolarization patterns. The extent and magnitude of ST depression also provide prognostic information beyond the binary TIMI criterion, as more extensive depression or depression greater than 2 millimeters indicates higher risk.
What role does the TIMI score play in emergency department disposition decisions?
The TIMI score is valuable in emergency department triage for patients presenting with chest pain and suspected acute coronary syndromes. Emergency physicians use the score alongside clinical judgment to determine the appropriate level of care and urgency of intervention. Patients with TIMI scores of 0 to 1 who have negative serial troponins and non-ischemic ECGs may be candidates for observation unit placement with early stress testing and potential discharge within 24 hours. Scores of 2 to 4 typically warrant hospital admission to a telemetry or step-down unit with cardiology consultation. Scores of 5 or higher often require intensive care or coronary care unit admission with urgent cardiology consultation for possible same-day catheterization. The score helps standardize disposition decisions and resource allocation in busy emergency departments.
How has the TIMI score been validated across different patient populations?
The TIMI Risk Score for UA/NSTEMI has been extensively validated since its original publication in 2000. The initial derivation cohort came from the TIMI 11B trial involving 1,957 patients, and it was immediately validated in the ESSENCE trial with 3,171 patients. Subsequent validation studies have been performed in numerous registries and clinical trials across different countries, healthcare systems, and patient demographics. The CRUSADE registry validated it in over 17,000 patients, confirming its discriminatory ability. Studies in elderly populations, diabetic patients, women, and various ethnic groups have generally supported its predictive value, though some subgroups show varying performance. A meta-analysis of validation studies showed consistent c-statistics between 0.63 and 0.70. While this moderate discrimination means the score is imperfect, it remains one of the most validated and widely used risk stratification tools in acute cardiology practice.
References
- Antman EM et al. The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI - JAMA 2000
- Amsterdam EA et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes
- Collet JP et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮TIMI Score for STEMI Calculator
Calculate timiscore for stemicalculator with inputs, formulas, and instant results.
🧮AUDIT Score Calculator
Calculate audit score with inputs, formulas, and instant results.
🧮Duke Treadmill Score Calculator
Calculate duke treadmill score with inputs, formulas, and instant results.
🧮Padua Score Calculator
Calculate padua score with inputs, formulas, and instant results.
🧮Revised Geneva Score Calculator
Calculate revised geneva score with inputs, formulas, and instant results.
🧮Diet Risk Score Calculator
Calculate diet risk score with inputs, formulas, and instant results.
🧮Bishop Score Calculator
Calculate bishop score with inputs, formulas, and instant results.
🧮Vterisk Score Calculator in Pregnancy
Calculate vterisk score in pregnancy with inputs, formulas, and instant results.